Champions Oncology
CSBR
CSBR
22 hedge funds and large institutions have $28.2M invested in Champions Oncology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $29.9M → $28.2M (-$1.69M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $73K
Holders
22
Holding in Top 10
1
Calls
–
Puts
$73K
Top Buyers
| 1 | +$100K | |
| 2 | +$71.6K | |
| 3 | +$52.4K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$24.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.4K |
Top Sellers
| 1 | -$102K | |
| 2 | -$56.6K | |
| 3 | -$52.8K | |
| 4 |
Renaissance Technologies
New York
|
-$12.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |